93
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Clinicopathological Features and Prognostic Outcomes of Papillary Renal Cell Carcinoma

, , &
Pages 7523-7531 | Published online: 02 Nov 2021

References

  • Keegan KA, Schupp CW, Chamie K, et al. Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. J Urol. 2012;188(2):391–397. doi:10.1016/j.juro.2012.04.006
  • Steffens S, Janssen M, Roos FC, et al. Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma–a multicentre study. Eur J Cancer. 2012;48(15):2347–2352. doi:10.1016/j.ejca.2012.05.002
  • Pignot G, Elie C, Conquy S, et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology. 2007;69(2):230–235. doi:10.1016/j.urology.2006.09.052
  • Akhtar M, Al-Bozom IA, Al Hussain T. Papillary Renal Cell Carcinoma (PRCC): an update. Adv Anat Pathol. 2019;26(2):124–132. doi:10.1097/PAP.0000000000000220
  • Amin MB, Corless CL, Renshaw AA, et al. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol. 1997;21(6):621–635. doi:10.1097/00000478-199706000-00001
  • Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol. 2019;75(5):799–810. doi:10.1016/j.eururo.2019.02.011
  • Rosiello G, Palumbo C, Knipper S, et al. Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis. World J Urol. 2021;39(2):461–472. doi:10.1007/s00345-020-03187-y
  • Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10(6):537–544.
  • Delahunt B, Eble JN, McCredie MR, et al. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol. 2001;32(6):590–595. doi:10.1053/hupa.2001.24984
  • Bigot P, Bernhard JC, Gill IS, et al. The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery. World J Urol. 2016;34(3):347–352. doi:10.1007/s00345-015-1634-0
  • Ledezma RA, Negron E, Paner GP, et al. Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery. World J Urol. 2016;34(5):687–693. doi:10.1007/s00345-015-1692-3
  • Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours. Eur Urol. 2016;70(1):93–105. doi:10.1016/j.eururo.2016.02.029
  • Ha YS, Chung JW, Choi SH, et al. Clinical significance of subclassification of papillary renal cell carcinoma: comparison of clinicopathologic parameters and oncologic outcomes between papillary histologic Subtypes 1 and 2 using the Korean renal cell carcinoma database. Clin Genitourin Cancer. 2017;15(2):e181–e186. doi:10.1016/j.clgc.2016.07.020
  • Yamashita S, Ioritani N, Oikawa K, et al. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis. Int J Urol. 2007;14(8):679–683. doi:10.1111/j.1442-2042.2007.01805.x
  • Patard JJ, Leray E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005;23(12):2763–2771. doi:10.1200/JCO.2005.07.055
  • Cornejo KM, Dong F, Zhou AG, et al. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome. Hum Pathol. 2015;46(10):1411–1417. doi:10.1016/j.humpath.2015.07.001
  • Ku JH, Moon KC, Kwak C, et al. Is there a role of the histologic subtypes of papillary renal cell carcinoma as a prognostic factor? Jpn J Clin Oncol. 2009;39(10):664–670. doi:10.1093/jjco/hyp075
  • Wong ECL, Di Lena R, Breau RH, et al. Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: type 1 vs. type 2. Urol Oncol. 2019;37(10):721–726. doi:10.1016/j.urolonc.2019.05.009
  • Selvi I, Demirci U, Bozdogan N, et al. The prognostic effect of immunoscore in patients with clear cell renal cell carcinoma: preliminary results. Int Urol Nephrol. 2020;52(1):21–34. doi:10.1007/s11255-019-02285-0
  • Delahunt B, Eble JN, Egevad L, et al. Grading of renal cell carcinoma. Histopathology. 2019;74(1):4–17. doi:10.1111/his.13735
  • Selvi I, Demirci U, Bozdogan N, Basar H. Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma? Int Urol Nephrol. 2021;53(6):1135–1138. doi:10.1007/s11255-020-02766-7